Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Vaccine symbols : SRNE save search
Sorrento Therapeutics has Received FDA Clearance to Initiate Clinical Trials with a Next Generation mRNA (STI-1557) Vaccine Against Omicron SARS-CoV-2 Virus
Published: 2022-12-06 (Crawled : 18:00) - biospace.com/
SRNE | $0.015 -8.85% 140K
|
Health Technology
|
| O: 1.68%
H: 0.0%
C: -7.02%
sti-1557 fda clearance trials vaccine mrna virus therapeutics sars-cov-2
Sorrento Reports Promising Results With a Universal Chimeric mRNA COVID-19 Vaccine That Elicits Potent Neutralizing Antibodies and Protection Against Omicron (BA.1 and BA.2) and Delta Variants
Published: 2022-03-20 (Crawled : 00:00) - globenewswire.com
SRNE | $0.015 -8.85% 140K
|
Health Technology
|
| O: 3.44%
H: 1.48%
C: -7.38%
covid-19 covid report results vaccine antibody
Anxious World Waits As Covid Vaccine Makers Address Omicron Variant
Published: 2021-12-07 (Crawled : 14:00) - prnewswire.com
GLAXF | News | $20.305 -14.18% 630
|
Health Technology
|
| O: 5.22%
H: 0.0%
C: -1.25%
JNJ | News | $149.56 0.3% 0.0% 9.1M
|
Health Technology
|
| O: 2.13%
H: 0.0%
C: 0.0%
GSK | News | $41.24 1.6% 0.0% 2.3M
|
Health Technology
|
| O: 0.14%
H: 0.0%
C: 0.0%
VIR | $8.13 0.37% 0.37% 770K
|
Health Technology
|
| O: -6.42%
H: 8.6%
C: 8.45%
SRNE | $0.015 -8.85% 140K
|
Health Technology
|
| O: 6.57%
H: 14.77%
C: 11.21%
RDHL | $0.4277 -3.32% -3.44% 470K
|
Health Technology
|
| O: 0.37%
H: 10.37%
C: 9.63%
covid vaccine
Sorrento Reports Promising Results With mRNA Vaccine For COVID-19 Delivered With The MuVaxx Lymphatic Drug Delivery Device
Published: 2021-08-26 (Crawled : 17:00) - globenewswire.com
SRNE | $0.015 -8.85% 140K
|
Health Technology
|
| O: 0.0%
H: 2.9%
C: -3.0%
covid results vaccine drug device drug delivery liver
Sorrento Announces Its Lead Protein-Based COVID-19 Vaccine Candidate – DYAI-100 – Elicits Strong Neutralizing Immune Responses in Vaccinated Animals Against SARS-CoV-2 and Multiple Major Variants of Concern
Published: 2021-08-19 (Crawled : 21:00) - globenewswire.com
SRNE | $0.015 -8.85% 140K
|
Health Technology
|
| O: 0.36%
H: 3.02%
C: 0.85%
DYAI A | $1.5 -1.96% -2.0% 8.8K
|
Health Technology
|
| O: -1.33%
H: 8.99%
C: 6.07%
covid animals vaccine sars-cov-2
Sorrento and Dyadic Announce Binding Term Sheet to License Dyadic’s Lead COVID-19 Vaccine Candidate “DYAI-100” and C1 Technology for Protein-Based Coronavirus Vaccines and Therapeutics
Published: 2021-08-11 (Crawled : 13:15) - biospace.com/
SRNE | $0.015 -8.85% 140K
|
Health Technology
|
| O: 0.0%
H: 1.36%
C: 0.68%
DYAI A | $1.5 -1.96% -2.0% 8.8K
|
Health Technology
|
| O: 20.33%
H: 28.7%
C: 22.22%
covid vaccine license technology
Dyadic and Sorrento Announce Binding Term Sheet to License Dyadic’s Lead COVID-19 Vaccine Candidate “DYAI-100” and C1 Technology for Protein-Based Coronavirus Vaccines and Therapeutics
Published: 2021-08-11 (Crawled : 13:00) - globenewswire.com
SRNE | $0.015 -8.85% 140K
|
Health Technology
|
| O: 0.0%
H: 1.36%
C: 0.68%
DYAI A | $1.5 -1.96% -2.0% 8.8K
|
Health Technology
|
| O: 20.33%
H: 28.7%
C: 22.22%
covid vaccine license technology
Sorrento Unveils Overview of Its MultiValent mRNA COVID-19 Vaccine Development Program
Published: 2021-08-09 (Crawled : 19:00) - globenewswire.com
SRNE | $0.015 -8.85% 140K
|
Health Technology
|
| O: -0.57%
H: 2.76%
C: 1.84%
covid vaccine covid-19
Gainers vs Losers
| 78% | 22% |
Top 10 Gainers
MTTR | News M | $4.6 164.37% 62.17% 28M
|
AGBA | $2.94 135.2% 57.48% 66M
|
Finance
EDBL | News | $6.46 71.81% 41.8% 2M
|
MTC | $2.25 44.23% 30.67% 6M
|
Technology Services
OPRT | News | $3.175 41.11% 29.13% 12M
|
Finance
SHIM | $3.05 35.56% 26.23% 1.1M
|
HKIT | $1.345 31.86% 24.16% 390K
|
Technology Services
ABVC | $1.36 30.77% 23.53% 7.4M
|
Wholesale Trade
OST | $0.512 28.0% 21.88% 290K
|
POET | $1.59 27.2% 21.38% 4.2M
|
Manufacturing
Your saved searches
Save your searches and get alerts when important news are released.